RACK1 promotes cancer progression by increasing the M2/M1 macrophage ratio via the NF‐κB pathway in oral squamous cell carcinoma
Receptor for activated C kinase 1 (RACK1) has been shown to promote oral squamous cell carcinoma (OSCC) progression, and RACK1 expression levels have been negatively correlated with prognosis in patients with OSCC. Here, we investigated the impact of RACK1 OSCC expression on the recruitment and diff...
Main Authors: | Hongxia Dan, Sai Liu, Jiajia Liu, Dongjuan Liu, Fengying Yin, Zihao Wei, Jiongke Wang, Yu Zhou, Lu Jiang, Ning Ji, Xin Zeng, Jing Li, Qianming Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-04-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12644 |
Similar Items
-
Deacylcynaropicrin Inhibits RANKL-Induced Osteoclastogenesis by Inhibiting NF-κB and MAPK and Promoting M2 Polarization of Macrophages
by: Zhikun Li, et al.
Published: (2019-06-01) -
Progranulin inhibits LPS-induced macrophage M1 polarization via NF-кB and MAPK pathways
by: Lianlian Liu, et al.
Published: (2020-06-01) -
Aloin Suppresses Lipopolysaccharide-Induced Inflammatory Response and Apoptosis by Inhibiting the Activation of NF-κB
by: Xuan Luo, et al.
Published: (2018-02-01) -
Regulatory Networks Involving STATs, IRFs, and NFκB in Inflammation
by: Ekaterini Platanitis, et al.
Published: (2018-11-01) -
Berbamine Exerts Anti-Inflammatory Effects via Inhibition of NF-κB and MAPK Signaling Pathways
by: Xiao-Jian Jia, et al.
Published: (2017-04-01)